199 related articles for article (PubMed ID: 17998390)
1. AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements.
Kovalchuk AL; duBois W; Mushinski E; McNeil NE; Hirt C; Qi CF; Li Z; Janz S; Honjo T; Muramatsu M; Ried T; Behrens T; Potter M
J Exp Med; 2007 Nov; 204(12):2989-3001. PubMed ID: 17998390
[TBL] [Abstract][Full Text] [Related]
2. Role of the translocation partner in protection against AID-dependent chromosomal translocations.
Jankovic M; Robbiani DF; Dorsett Y; Eisenreich T; Xu Y; Tarakhovsky A; Nussenzweig A; Nussenzweig MC
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):187-92. PubMed ID: 19966290
[TBL] [Abstract][Full Text] [Related]
3. AID and Igh switch region-Myc chromosomal translocations.
Unniraman S; Schatz DG
DNA Repair (Amst); 2006 Sep; 5(9-10):1259-64. PubMed ID: 16784901
[TBL] [Abstract][Full Text] [Related]
4. AID is required for c-myc/IgH chromosome translocations in vivo.
Ramiro AR; Jankovic M; Eisenreich T; Difilippantonio S; Chen-Kiang S; Muramatsu M; Honjo T; Nussenzweig A; Nussenzweig MC
Cell; 2004 Aug; 118(4):431-8. PubMed ID: 15315756
[TBL] [Abstract][Full Text] [Related]
5. Myc translocations in B cell and plasma cell neoplasms.
Janz S
DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation promotes activation-induced cytidine deaminase activity at the Myc oncogene.
Mu Y; Zelazowska MA; McBride KM
J Exp Med; 2017 Dec; 214(12):3543-3552. PubMed ID: 29122947
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.
Park ES; Shaughnessy JD; Gupta S; Wang H; Lee JS; Woo HG; Zhan F; Owens JD; Potter M; Janz S; Mushinski JF
BMC Genomics; 2007 Aug; 8():302. PubMed ID: 17764563
[TBL] [Abstract][Full Text] [Related]
8. A role for AID in chromosome translocations between c-myc and the IgH variable region.
Dorsett Y; Robbiani DF; Jankovic M; Reina-San-Martin B; Eisenreich TR; Nussenzweig MC
J Exp Med; 2007 Sep; 204(9):2225-32. PubMed ID: 17724134
[TBL] [Abstract][Full Text] [Related]
9. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma.
Shaughnessy J; Wiener F; Huppi K; Mushinski JF; Potter M
Oncogene; 1994 Jan; 9(1):247-53. PubMed ID: 8302586
[TBL] [Abstract][Full Text] [Related]
10. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
[TBL] [Abstract][Full Text] [Related]
11. Fatal acute lymphoblastic leukemia in mice transgenic for B cell-restricted bcl-xL and c-myc.
Swanson PJ; Kuslak SL; Fang W; Tze L; Gaffney P; Selby S; Hippen KL; Nunez G; Sidman CL; Behrens TW
J Immunol; 2004 Jun; 172(11):6684-91. PubMed ID: 15153484
[TBL] [Abstract][Full Text] [Related]
12. Identification of an AID-independent pathway for chromosomal translocations between the Igh switch region and Myc.
Unniraman S; Zhou S; Schatz DG
Nat Immunol; 2004 Nov; 5(11):1117-23. PubMed ID: 15489857
[TBL] [Abstract][Full Text] [Related]
13. c-myc gene in a murine plasmocytoma without visible chromosomal translocations moves to chromosome 12F1 with Pvt-1 and rearranges with IgH enhancer-S mu sequences.
Ohno S; Migita S; Murakami S
Int J Cancer; 1991 Aug; 49(1):102-8. PubMed ID: 1874562
[TBL] [Abstract][Full Text] [Related]
14. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations.
Ramiro AR; Jankovic M; Callen E; Difilippantonio S; Chen HT; McBride KM; Eisenreich TR; Chen J; Dickins RA; Lowe SW; Nussenzweig A; Nussenzweig MC
Nature; 2006 Mar; 440(7080):105-9. PubMed ID: 16400328
[TBL] [Abstract][Full Text] [Related]
15. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development.
Takizawa M; Tolarová H; Li Z; Dubois W; Lim S; Callen E; Franco S; Mosaico M; Feigenbaum L; Alt FW; Nussenzweig A; Potter M; Casellas R
J Exp Med; 2008 Sep; 205(9):1949-57. PubMed ID: 18678733
[TBL] [Abstract][Full Text] [Related]
16. E mu/S mu transposition into Myc is sometimes a precursor for T(12;15) translocation in mouse B cells.
Kovalchuk AL; Kim JS; Janz S
Oncogene; 2003 May; 22(18):2842-50. PubMed ID: 12743607
[TBL] [Abstract][Full Text] [Related]
17. Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice.
Kotani A; Kakazu N; Tsuruyama T; Okazaki IM; Muramatsu M; Kinoshita K; Nagaoka H; Yabe D; Honjo T
Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1616-20. PubMed ID: 17251349
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of AID leads to tumorigenesis.
Okazaki IM; Hiai H; Kakazu N; Yamada S; Muramatsu M; Kinoshita K; Honjo T
J Exp Med; 2003 May; 197(9):1173-81. PubMed ID: 12732658
[TBL] [Abstract][Full Text] [Related]
19. Genetic recombinations between c-myc and Igh mu as precursors for recombinations between c-myc and Igh alpha in BALB/c plasmacytomas.
Janz S; Kovalchuk AL; Müller JR; Potter M
Curr Top Microbiol Immunol; 1997; 224():241-50. PubMed ID: 9308247
[TBL] [Abstract][Full Text] [Related]
20. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
